Timothy Hoff1, Adrienne Hoyt, Brad Therrell, Maria Ayoob. 1. Department of Health Policy, Management, and Behavior, School of Public Health, State University of New York at Albany, 1 University Place, Rensselaer, NY 12144, USA.
Abstract
PURPOSE: To inform current policy debate regarding the public health role in long-term follow-up for individuals with disorders identified through state newborn testing efforts, by identifying and assessing key challenges, quality assurance activities, and long-term follow-up perceptions of state newborn screening programs. METHODS: A 23-question, web-based survey sent to newborn screening programs in all 50 states and Washington, DC, during January and February, 2005. RESULTS: Many U.S. newborn screening programs do not currently engage in structured long-term follow-up for newborns with diagnosed disorders. The newborn screening programs that do long-term follow-up face various challenges that may impact their ability to perform it effectively. Barriers include a lack of comprehensive quality assurance practices, outsourcing, financial constraints, and perceived communication problems with providers who treat these patients. CONCLUSIONS: A more in-depth analysis of the desired and feasible roles that should be played by newborn screening programs in long-term follow-up is needed. The wide variability within programs regarding the structure and implementation of long-term follow-up, and the relative absence of long-term follow-up systems components in some newborn screening programs, poses an interesting question regarding responsibility for evaluation of longer-term outcomes associated with newborn testing and disorder diagnosis.
PURPOSE: To inform current policy debate regarding the public health role in long-term follow-up for individuals with disorders identified through state newborn testing efforts, by identifying and assessing key challenges, quality assurance activities, and long-term follow-up perceptions of state newborn screening programs. METHODS: A 23-question, web-based survey sent to newborn screening programs in all 50 states and Washington, DC, during January and February, 2005. RESULTS: Many U.S. newborn screening programs do not currently engage in structured long-term follow-up for newborns with diagnosed disorders. The newborn screening programs that do long-term follow-up face various challenges that may impact their ability to perform it effectively. Barriers include a lack of comprehensive quality assurance practices, outsourcing, financial constraints, and perceived communication problems with providers who treat these patients. CONCLUSIONS: A more in-depth analysis of the desired and feasible roles that should be played by newborn screening programs in long-term follow-up is needed. The wide variability within programs regarding the structure and implementation of long-term follow-up, and the relative absence of long-term follow-up systems components in some newborn screening programs, poses an interesting question regarding responsibility for evaluation of longer-term outcomes associated with newborn testing and disorder diagnosis.
Authors: Judith Livingston; Bradford L Therrell; Marie Y Mann; Carolyn Stady Anderson; Katherine Christensen; Jerome L Gorski; Dorothy K Grange; Dawn Peck; Margy Roberston; Sharmini Rogers; Maura Taylor; Celia I Kaye Journal: J Community Genet Date: 2011-07-06
Authors: Cynthia F Hinton; Charles J Homer; Alexis A Thompson; Andrea Williams; Kathryn L Hassell; Lisa Feuchtbaum; Susan A Berry; Anne Marie Comeau; Bradford L Therrell; Amy Brower; Katharine B Harris; Christine Brown; Jana Monaco; Robert J Ostrander; Alan E Zuckerman; Celia Kaye; Denise Dougherty; Carol Greene; Nancy S Green Journal: Mol Genet Metab Date: 2016-05-31 Impact factor: 4.797
Authors: Cynthia F Hinton; Cara T Mai; Sarah K Nabukera; Lorenzo D Botto; Lisa Feuchtbaum; Paul A Romitti; Ying Wang; Kimberly Noble Piper; Richard S Olney Journal: Genet Med Date: 2013-12-05 Impact factor: 8.822